By Halimatou Jallow
The Gambia has taken a decisive stride toward securing a brighter, healthier future for its youngest citizens with launch of drive towards ending Mother-to-child transmission of HiV, Syphilis, and Hepatitis B.
The workshop, held recently, served as the launchpad for an intensified campaign, orchestrated by the National Hepatitis Control Program of the Ministry of Health in collaboration with international partners Fujirebio-Japan and the Medical Research Council Unit, The Gambia at LSHTM. Together, they have set a bold, accelerated course for the nation: achieving the 2030 World Health Organization (WHO) goal of ‘triple elimination’, the complete eradication of mother-to-child transmission of HIV, Hepatitis B, and Syphilis.
The alliance brought together high-level policymakers, representatives from key international bodies like the WHO and The Global Fund, on-the-ground health implementers, cutting-edge diagnostic experts, and vital community advocates. Their shared, unambiguous mandate is to seamlessly integrate life-saving screening and treatment protocols for all three conditions directly into the core antenatal care (ANC) services across the country. This integration means a profound shift: every expectant mother will be able to access comprehensive, coordinated care in a single location, simplifying the process and guaranteeing a stronger, healthier start for her baby’s life.
The Gambia’s dedication has already yielded tangible results; the country has made notable headway in suppressing the vertical transmission of HIV and syphilis through enhanced healthcare infrastructure and strategic, long-term partnerships. However, the path ahead still holds a significant challenge in the form of Hepatitis B. Historically, a substantial number of pregnant women at risk have remained undetected, allowing the virus to silently pass to infants. The workshop addressed this gap head-on, focusing on a key technological breakthrough: the potential deployment of innovative diagnostic tools. Specifically, the highly sensitive HBeAg rapid test was discussed. This portable technology offers the prospect of identifying high-risk women swiftly and accurately right within their local communities and clinics, closing a crucial diagnostic gap and ensuring timely, life-saving intervention for both mother and child.
This critical public health mission is substantially enabled by the generous financial and technical backing of the Ministry of Health, Labour and Welfare, Japan.
The Gambian Ministry of Health expressed appreciation to the Government of Japan for their essential investment.
With a clear, detailed, and actionable operational roadmap now firmly in place, the powerful drive toward Triple Elimination is no longer a vision but a reality in motion.
